ArticleCureus2025
Diagnostic Delay in Acromegaly Due to Overlapping Features With Polycystic Ovary Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acromegaly is a rare endocrine disorder marked by excessive secretion of growth hormone, typically as a result of a pituitary adenoma. This condition in female patients often presents with features that may overlap with polycystic ovary syndrome (PCOS), potentially leading to misdiagnosis or delayed diagnosis. This case study looks at a 33-year-old woman initially diagnosed with PCOS due to hirsutism, secondary amenorrhea, and features of polycystic ovaries on ultrasound. One year later, she experienced progressive visual disturbances and headaches, leading to the discovery of a large pituitary macroadenoma via MRI. Subsequent hormonal evaluation revealed elevated insulin-like growth factor 1 (IGF-1) and growth hormone levels, culminating in a diagnosis of acromegaly. The patient underwent successful endoscopic debulking of the adenoma with no residual disease detected on subsequent imaging. Post-operative management included Lanreotide therapy for persistently elevated IGF-1 levels. This case emphasises the importance of considering acromegaly in women with menstrual irregularities and hyperandrogenism, highlighting the need for comprehensive assessments to facilitate early diagnosis and address potential complications, such as vision loss and fertility issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.